In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $40.02 in the prior trading day, CRISPR Therapeutics AG (NASDAQ: CRSP) closed at $38.65, down -3.42%. In other words, the price has decreased by -$3.42 from its previous closing price. On the day, 2.18 million shares were traded. CRSP stock price reached its highest trading level at $39.67 during the session, while it also had its lowest trading level at $38.2.
Ratios:
Our goal is to gain a better understanding of CRSP by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.64 and its Current Ratio is at 21.64. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on August 06, 2024, Reiterated its Buy rating but revised its target price to $84 from $88 previously.
On August 02, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $90.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 ’24 when Kulkarni Samarth sold 15,000 shares for $55.10 per share. The transaction valued at 826,564 led to the insider holds 181,540 shares of the business.
Kulkarni Samarth sold 30,000 shares of CRSP for $1,668,678 on Nov 11 ’24. The Chief Executive Officer now owns 196,540 shares after completing the transaction at $55.62 per share. On Oct 14 ’24, another insider, KASINGER JAMES R., who serves as the General Counsel and Secretary of the company, sold 1,089 shares for $46.28 each. As a result, the insider received 50,399 and left with 62,597 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRSP now has a Market Capitalization of 3298913024 and an Enterprise Value of 1590811904. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.85 while its Price-to-Book (P/B) ratio in mrq is 1.70. Its current Enterprise Value per Revenue stands at 7.843 whereas that against EBITDA is -5.081.
Stock Price History:
Over the past 52 weeks, CRSP has reached a high of $91.10, while it has fallen to a 52-week low of $39.41. The 50-Day Moving Average of the stock is -18.79%, while the 200-Day Moving Average is calculated to be -27.01%.
Shares Statistics:
The stock has traded on average 1.60M shares per day over the past 3-months and 1929540 shares per day over the last 10 days, according to various share statistics. A total of 85.34M shares are outstanding, with a floating share count of 81.70M. Insiders hold about 4.28% of the company’s shares, while institutions hold 69.47% stake in the company. Shares short for CRSP as of 1734048000 were 18116755 with a Short Ratio of 11.35, compared to 1731628800 on 19390540. Therefore, it implies a Short% of Shares Outstanding of 18116755 and a Short% of Float of 24.059999.
